TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Pharma Inc AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
23,857
|
23,184
|
18,643 |
| Financial expenses |
2,061
|
3,813
|
4,242 |
| Earnings before taxes |
4,506
|
3,014
|
4,021 |
| Total assets |
42,512
|
40,959
|
43,275 |
| Current assets |
18,647
|
14,030
|
14,926 |
| Current liabilities |
3,219
|
2,231
|
2,693 |
| Equity capital |
27,872
|
25,663
|
24,895 |
| - share capital |
2,356
|
2,483
|
2,651 |
| Employees (average) | 39 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.6%
|
62.7%
|
57.5% |
| Turnover per employee | 612 | ||
| Profit as a percentage of turnover |
18.9%
|
13.0%
|
21.6% |
| Return on assets (ROA) |
15.4%
|
16.7%
|
19.1% |
| Current ratio |
579.3%
|
628.9%
|
554.3% |
| Return on equity (ROE) |
16.2%
|
11.7%
|
16.2% |
| Change turnover |
1,858
|
5,725
|
2,016 |
| Change turnover % |
8%
|
33%
|
12% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.